• Boston Scientific (Natick, Massachusetts) said that President/CEO Jim Tobin will be extending his tenure at the company, and that Fred Colen will become the president of its cardiac rhythm management (CRM) group. COO Paul LaViolette will be retiring from the company. Colen has been with Boston Sci since 1999, most recently as executive VP of operations and technology, CRM. LaViolette joined the company in 1994, and has been COO since 2005.

• Signalife (Los Angeles) said that it has named Lee Ehrlichman, a member of the company's board, as president/COO. Ehrlichman previously was president/CEO of Cardiac Telecom. Lowell Harmison, Signalife's prior president/CEO, has taken an indefinite leave of absence as both an officer and director, during which he is expected to consult to the company. Rowland Perkins, previously Signalife's interim administrative CEO, will assume all duties of CEO. Signalife specializes in monitoring, detection and prevention of disease through continuous biomedical signal monitoring.